Skip to content
10-Q

Quarterly Report

GENELINK INC

0001144204-12-061929

← back to feed
Filed
Nov 14, 2012 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Nov 14, 2012 253.35M sh
Stockholders Equity Q3 2012 · Sep 30, 2012 −$2.9M
Stockholders Equity Q3 2012 · Dec 31, 2011 −$1.48M
Current Liabilities Q3 2012 · Sep 30, 2012 $3.31M
Current Liabilities Q3 2012 · Dec 31, 2011 $2.3M
Total Liabilities Q3 2012 · Sep 30, 2012 $5.59M
Total Liabilities Q3 2012 · Dec 31, 2011 $4.26M
Current Assets Q3 2012 · Sep 30, 2012 $1.78M
Current Assets Q3 2012 · Dec 31, 2011 $1.86M
Total Assets Q3 2012 · Sep 30, 2012 $2.7M
Total Assets Q3 2012 · Dec 31, 2011 $2.78M
Capex Q3 2012 · Sep 30, 2011 $41.35K
Operating Cash Flow restated Q3 2012 · Sep 30, 2011 −$2.13M
Cash And Equivalents restated Q3 2012 · Sep 30, 2011 $494.59K
Cash And Equivalents Q3 2012 · Jun 30, 2011 $347.93K
Cash And Equivalents Q3 2012 · Dec 31, 2010 $429.3K
Sga Expense restated Q3 2012 · Sep 30, 2011 $1.47M
Sga Expense restated Q3 2012 · Sep 30, 2011 $4.43M
Rd Expense Q3 2012 · Sep 30, 2011 $43.71K
Rd Expense restated Q3 2012 · Sep 30, 2011 $60.33K
Net Income restated Q3 2012 · Sep 30, 2011 −$977.99K
Net Income restated Q3 2012 · Sep 30, 2011 −$2.4M
Operating Income restated Q3 2012 · Sep 30, 2011 −$912.29K
Operating Income restated Q3 2012 · Sep 30, 2011 −$2.2M
Gross Profit Q3 2012 · Sep 30, 2011 $631.32K
Gross Profit Q3 2012 · Sep 30, 2011 $2.4M
Cost Of Revenue Q3 2012 · Sep 30, 2011 $438.44K
Cost Of Revenue Q3 2012 · Sep 30, 2011 $1.4M